Arcutis Book Value Per Share from 2010 to 2024

ARQT Stock

USD 12.25 0.52 4.07%

Arcutis Biotherapeutics Book Value Per Share yearly trend continues to be comparatively stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2024. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Arcutis Biotherapeutics according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

1.27936479

Current Value

1.85

Quarterly Volatility

2.63886776

Credit Downgrade

Yuan Drop

Covid

Check Arcutis Biotherapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Arcutis Biotherapeutics' main balance sheet or income statement drivers, such as Interest Expense of 31.2 M, Selling General Administrative of 182.2 M or Total Revenue of 62.6 M, as well as many indicators such as Price To Sales Ratio of 3.57, Dividend Yield of 0.0 or PTB Ratio of 2.65. Arcutis financial statements analysis is a perfect complement when working with Arcutis Biotherapeutics Valuation or Volatility modules.

Check out the analysis of Arcutis Biotherapeutics Correlation against competitors.

For more information on how to buy Arcutis Stock please use our How to Invest in Arcutis Biotherapeutics guide.

Latest Arcutis Biotherapeutics' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Arcutis Biotherapeutics over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Arcutis Biotherapeutics' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcutis Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.34 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Arcutis Book Value Per Share Regression Statistics

	Arithmetic Mean	1.14
	Geometric Mean	0.52
	Coefficient Of Variation	231.77
	Mean Deviation	1.98
	Median	(0.14)
	Standard Deviation	2.64
	Sample Variance	6.96
	Range	9.2945
	R-Value	0.52
	Mean Square Error	5.45
	R-Squared	0.27
	Significance	0.05
	Slope	0.31
	Total Sum of Squares	97.49

Arcutis Book Value Per Share History

	2024	1.85
	2023	1.28
	2022	3.81
	2021	6.03
	2020	7.59
	2019	-1.71
	2018	-0.66

Other Fundumenentals of Arcutis Biotherapeutics

Tangible Book Value Per Share

Arcutis Biotherapeutics Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Long Term Debt Total	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Net Receivables	Short Term Debt	Common Stock	Property Plant Equipment	Intangible Assets
Total Assets		0.87	0.92	0.53	-0.82	0.94	0.86	0.82	0.93	0.78	0.97	1.0	1.0	0.53	0.93	0.96	0.82	-0.34
Total Stockholder Equity	0.87		0.95	0.28	-0.57	0.77	0.54	0.59	0.8	0.38	0.93	0.88	0.88	0.26	0.76	0.9	0.6	-0.18
Net Tangible Assets	0.92	0.95		0.4	-0.71	0.9	0.67	0.65	0.88	0.52	0.96	0.92	0.91	0.44	0.87	0.95	0.72	-0.27
Net Debt	0.53	0.28	0.4		-0.84	0.61	0.71	0.33	0.69	0.64	0.57	0.52	0.51	0.81	0.73	0.57	0.85	-0.63
Retained Earnings	-0.82	-0.57	-0.71	-0.84		-0.89	-0.9	-0.74	-0.94	-0.83	-0.79	-0.82	-0.8	-0.92	-0.94	-0.86	-0.99	0.75
Accounts Payable	0.94	0.77	0.9	0.61	-0.89		0.91	0.8	0.94	0.8	0.92	0.94	0.93	0.69	0.98	0.94	0.89	-0.44
Long Term Debt	0.86	0.54	0.67	0.71	-0.9	0.91		0.86	0.85	0.95	0.78	0.86	0.85	0.75	0.92	0.81	0.9	-0.5
Long Term Debt Total	0.82	0.59	0.65	0.33	-0.74	0.8	0.86		0.78	0.81	0.67	0.82	0.82	0.58	0.75	0.78	0.72	-0.48
Capital Surpluse	0.93	0.8	0.88	0.69	-0.94	0.94	0.85	0.78		0.74	0.92	0.93	0.92	0.77	0.97	0.98	0.95	-0.63
Total Liab	0.78	0.38	0.52	0.64	-0.83	0.8	0.95	0.81	0.74		0.65	0.78	0.77	0.68	0.8	0.67	0.79	-0.42
Net Invested Capital	0.97	0.93	0.96	0.57	-0.79	0.92	0.78	0.67	0.92	0.65		0.97	0.96	0.5	0.93	0.96	0.8	-0.3
Total Current Assets	1.0	0.88	0.92	0.52	-0.82	0.94	0.86	0.82	0.93	0.78	0.97		1.0	0.53	0.93	0.96	0.82	-0.34
Net Working Capital	1.0	0.88	0.91	0.51	-0.8	0.93	0.85	0.82	0.92	0.77	0.96	1.0		0.51	0.92	0.95	0.81	-0.33
Net Receivables	0.53	0.26	0.44	0.81	-0.92	0.69	0.75	0.58	0.77	0.68	0.5	0.53	0.51		0.76	0.65	0.9	-0.91
Short Term Debt	0.93	0.76	0.87	0.73	-0.94	0.98	0.92	0.75	0.97	0.8	0.93	0.93	0.92	0.76		0.95	0.95	-0.54
Common Stock	0.96	0.9	0.95	0.57	-0.86	0.94	0.81	0.78	0.98	0.67	0.96	0.96	0.95	0.65	0.95		0.88	-0.51
Property Plant Equipment	0.82	0.6	0.72	0.85	-0.99	0.89	0.9	0.72	0.95	0.79	0.8	0.82	0.81	0.9	0.95	0.88		-0.75
Intangible Assets	-0.34	-0.18	-0.27	-0.63	0.75	-0.44	-0.5	-0.48	-0.63	-0.42	-0.3	-0.34	-0.33	-0.91	-0.54	-0.51	-0.75

Click cells to compare fundamentals

About Arcutis Biotherapeutics Financial Statements

Arcutis Biotherapeutics shareholders use historical fundamental indicators, such as Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Arcutis Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Arcutis Biotherapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcutis Biotherapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	1.28	1.85
Tangible Book Value Per Share	1.19	1.82

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Arcutis Stock Analysis

When running Arcutis Biotherapeutics' price analysis, check to measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC